Supply issues and spotty insurance coverage have driven some patients to seek out compounded versions of the drug, which tend to be less expensive
The entire compounded GLP-1 market is driven by patients who need or want tirzepatide but cannot afford over $1,000 per month for brand-name products
Healthon clinicians can help patients determine eligibility, navigate insurance requirements, and design personalized treatment plans for effective weight and diabetes management
Key Takeaways Most GLP patches are marketing, not medicine: there is no strong clinical evidence that a skin patch delivers GLP-1 level weight loss on its own
Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan
Based on the philosophy of "Human-orient, Technical first, Quality product and High efficiency, Fact and Innovation", JL Pharm highly welcome friends from all over the world to cooperate and get co-development